Symbio LLC has signed a five-year contract with OmniComm Systems, Inc. Under the agreement, Symbio will use OmniComm’s TrialMaster version 5 to develop and manage clinical study databases. Additonally, in 2018, Symbio launched its European operations to support clients with global trials. With the opening of that division, OmniComm’s data center in Europe became a major factor in the selection of TrialMaster. Symbio cited the stability and excellent performance of OmniComm’s EDC technology, TrialMaster’s randomization capability, and the ability to create submission-ready CRFs, ad hoc reports and customized reports to address sponsors’ needs and requests as contributing factors to its decision.